Intestinal infections in enteric
diseases can range from asymptomatic and mild to severe symptoms including
abdominal cramps, vomiting, nausea and anorexia. Severe cases and symptoms
under some cases may even lead to death as well due to heavy loss of fluids and
essential nutrients from the body.
Statistics:
The global Enteric
Disease Testing Market is estimated to account for US$ 3,732.7 Mn in terms
of value by the end of 2020.
Global Enteric Disease Testing
Market: Drivers
High incidence of typhoid fever
is expected to propel growth of the global enteric disease testing market over
the forecast period. For instance, according to the study, ‘The global burden
of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden
of Disease Study 2017’, published in February 2019, globally, 14·3 million
cases of typhoid and paratyphoid fevers occurred in 2017.
Global Enteric Disease Testing
Market: Opportunities
R&D of new approaches is
expected to offer lucrative growth opportunities for players in the global
enteric disease testing market. For instance, in August 2020, researchers at
Purdue University, U.S., reported development of a new 3D-printed capsule that
allows sampling of gut bacteria for further analysis and possible identification
of disease.
* The sample copy includes: Report Summary, Table of
Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copy
of this report: https://www.coherentmarketinsights.com/insight/request-sample/1164
Global Enteric Disease Testing
Market: Restraints
Low public heath expenditure,
especially in emerging economies, is expected to hinder growth of the global
enteric disease testing market.
Key Takeaways:
The global enteric disease
testing market was valued at US$ 3,643.4 Mn in 2019 and is forecast to reach a
value of US$ 4,432.7 Mn by 2027 at a CAGR of 2.5% between 2020 and 2027. High
incidence of typhoid fever is expected to propel growth of the global enteric
disease testing market over the forecast period.
Market Trend
R&D in enteric diseases is
expected to propel growth of the global enteric disease testing market. For
instance, in June 2020, researchers from University of Texas Southwestern
Medical Center, U.S., reported that l-arginine sensing regulates virulence gene
expression and disease progression in enteric pathogens.
Moreover, adoption of satellite
observations in disease models is also expected to aid in growth of the market.
Researchers can use Earth observing satellites to track when and where certain
diseases will emerge and spread.
Browse Research
Report: https://www.coherentmarketinsights.com/market-insight/enteric-disease-testing-market-1164
Global Enteric Disease Testing
Market: Competitive Landscape
Major players operating in the
global enteric disease testing market include, Alere, Inc., Becton Dickinson
& Company, Biomerica, Inc., bioMerieux, Bio-Rad, Cepheid, Coris BioConcept,
DiaSorin, Meridian Bioscience, Inc., Quest Diagnostics, and Trinity Biotech.
Global Enteric Disease Testing
Market: Key Developments
Major players in the global
enteric disease testing market are focused on approval and launch of new
products to expand their product portfolio. For instance, in December 2018,
Becton, Dickinson and Company received U.S. Food and Drug Administration (FDA)
510(k) clearance for its BD Max enteric viral panel, a molecular diagnostic
test for the detection and differentiation of pathogens that cause viral
gastroenteritis.
Buy-Now this research
report: https://www.coherentmarketinsights.com/insight/buy-now/1164
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis, consulting
services, and competitive analysis through various recommendations related to
emerging market trends, technologies, and potential absolute dollar
opportunity.
Contact
Us:
mailto:sales@coherentmarketinsights.com
U.S.
Office:
Name: Mr. Shah
Coherent
Market Insights 1001 4th Ave,
# 3200
Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN
: +050-5539-1737
